Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP.
PHASE2
The probability to achieve CR with R-chemotherapy in patients failing a rit...
Status
Completed
Location
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Ematologia
A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
PHASE3
The study will be conducted in compliance with the International Council fo...
R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
PHASE2
Prospective, multicenter, open label, phase II randomized clinical trial in...
Status
Withdrawn
Location
A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia